Henry Schein Inc. Stock
Henry Schein Inc. Stock
We can see a decrease in the price for Henry Schein Inc.. Compared to yesterday it has lost -€1.000 (-1.300%).
Currently there is a rather positive sentiment for Henry Schein Inc. with 13 Buy predictions and 3 Sell predictions.
With a target price of 78 € there is a slightly positive potential of 1.96% for Henry Schein Inc. compared to the current price of 76.5 €.
Our community identified positive and negative aspects for Henry Schein Inc. stock for the coming years. 0 users see the criterium "Company culture" as a plus for the Henry Schein Inc. stock. On the other hand our users think that "Company culture" could be a problem in the future.
Pros and Cons of Henry Schein Inc. in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Henry Schein Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Henry Schein Inc. | -1.300% | 2.685% | 0.000% | 35.255% | 17.801% | 10.934% | 18.019% |
| Dexcom Inc. | 0.550% | 1.381% | 13.622% | 11.941% | 28.053% | -33.224% | -33.182% |
| Baxter International | 0.680% | 5.026% | 18.981% | 17.950% | 46.207% | -39.848% | -62.571% |
| Idexx Laboratories Inc. | -0.510% | 4.725% | 1.622% | -9.032% | -13.171% | 9.894% | -12.813% |
Comments
Henry Schein (HSIC) had its "buy" rating reaffirmed by BTIG Research. They now have a $100.00 price target on the stock.
Show more
Ratings data for HSIC provided by MarketBeat
Henry Schein (HSIC) had its "buy" rating reaffirmed by Citigroup Inc..
Show more
Ratings data for HSIC provided by MarketBeat
Henry Schein (HSIC) had its price target raised by Piper Sandler from $91.00 to $95.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for HSIC provided by MarketBeat